Skip to content
NewsBlazeIN – Lifestyle
Author:
24/7 Market News and NeOnc Technology
NeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations
November 12, 2026
FDA Meeting Could Put NeOnc’s NEO100 Experimental Brain Cancer Drug on Faster Track
November 11, 2026
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
November 2, 2026
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
October 30, 2026
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
October 26, 2026
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
October 23, 2026
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
October 22, 2026
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
October 21, 2026
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
October 20, 2026
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
October 16, 2026
1
2
3
4
Next Page
→